Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
Revance Therapeutics, Inc. (RVNC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2018 |
BW
| Revance Releases First Quarter 2018 Results |
| 04/24/2018 |
BW
| Revance Therapeutics to Release First Quarter 2018 Financial Results on Tuesday, May 8, 2018 |
| 02/28/2018 |
BW
| Revance Releases Fourth Quarter and Full Year 2017 Results |
| 02/22/2018 |
BW
| Revance Therapeutics to Release Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 28, 2018 |
| 12/05/2017 |
BW
| Revance's RT002 Meets Primary and All Secondary Endpoints, Achieves 6-Month Duration in Pivotal SAKURA Phase 3 Trials for Glabellar Lines |
| 11/02/2017 |
BW
| Revance Releases Third Quarter 2017 Results |
| 10/18/2017 |
BW
| Revance Therapeutics to Release Third Quarter 2017 Financial Results Thursday, November 2, 2017 |
| 08/30/2017 |
BW
| Revance to Participate in the 2017 Wells Fargo Securities Healthcare Conference |
| 08/03/2017 |
BW
| Revance Releases Second Quarter 2017 Results |
| 07/24/2017 |
BW
| Revance Therapeutics to Release Second Quarter 2017 Financial Results Thursday, August 3, 2017 |
| 06/01/2017 |
BW
| Revance to Participate in Upcoming Investor Conferences |
| 05/18/2017 |
BW
| Revance Announces Positive Top-Line 24-Week Duration of Effect Results in All Three Cohorts in RT002 Injectable Phase 2 Cervical Dystonia Trial |
| 05/09/2017 |
BW
| Revance Releases First Quarter 2017 Results |
| 04/25/2017 |
BW
| Revance Therapeutics to Release First Quarter 2017 Financial Results Tuesday, May 9, 2017 |
| 02/27/2017 |
BW
| Revance Releases Fourth Quarter and Full Year 2016 Results |
| 02/16/2017 |
BW
| Revance Therapeutics to Release Fourth Quarter 2016 Financial Results Monday, February 27, 2017 |
|
|